欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5505/001
药品名称Nab-Paclitaxel STADA
活性成分
    • paclitaxel 5.0 mg/ml
剂型Powder for dispersion for infusion
上市许可持有人Stada Arzneimittel AG
参考成员国 - 产品名称Netherlands (NL)
Nab-Paclitaxel STADA
互认成员国 - 产品名称
    • Norway (NO)
    • Finland (FI)
    • Hungary (HU)
      Nab-Paclitaxel Stada 5 mg/ml por szuszpenziós infúzióhoz
    • Germany (DE)
      Paclitaxel STADA 5 mg/ml Pulver zur Herstellung einer Infusionsdispersion
    • Romania (RO)
    • Denmark (DK)
      Bugvi
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Sweden (SE)
许可日期2024/05/02
最近更新日期2024/10/28
药物ATC编码
    • L01CD01 paclitaxel
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase